Back to Authors

Henderson, Robert D.

0000-0002-2820-8183

A5048588036 | I165143802

Mayo Clinic

The University of Queensland

Citations 5

Phase II/III Study of Ulviprubart in Inclusion Body Myositis: Study Design, Patient Characteristics, and Topline Results (S7.007)

Neurology | June 10, 2026 | Volume: 106 | Issue: 11_Supplement_1 | Pages: No page available

10.1212/wnl.0000000000215166

A Phase 2, Double-Blind, Randomized, Dose-Ranging Trial Of Reldesemtiv In Patients With ALS

Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration | September 24, 2020 | Volume: 22 | Issue: 3-4 | Pages: 287-299

10.1080/21678421.2020.1822410 | PMID 32969758

Decrement in surface-recorded motor unit potentials in amyotrophic lateral sclerosis

Neurology | May 13, 2012 | Volume: 63 | Issue: 9 | Pages: 1670-1674

10.1212/01.wnl.0000142534.78461.42 | PMID 15534253

The morbidity of Guillain-BarreĢ syndrome admitted to the intensive care unit

Neurology | May 13, 2012 | Volume: 60 | Issue: 1 | Pages: 17-21

10.1212/01.wnl.0000035640.84053.5b | PMID 12530364

Optimal stimulation settings for CMAP scan registrations

Journal of Brachial Plexus and Peripheral Nerve Injury | April 30, 2012 | Volume: 07 | Issue: 01 | Pages: e1-e7

10.1186/1749-7221-7-4 | PMID 22546084